OM DENNE EPISODE
June 27th 2024 – Join us this week as we speak with Kevin Neil and Jean-François Millau from Tatum Bioscience in Sherbrooke, Quebec. Kevin and Jean-François are a part of a team that are ‘programming’ bacteria to turn them into cancer-fighting drugs and the work they are doing is cutting edge.
TATUM Bioscience: tatumbio.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com
Lab Occupier: laboccupier.com
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØK BLANT TIDLIGERE EPISODER
Søk etter gamle episoder av NGBiLab.
ANDRE EPISODE I DENNE PODKAST
Join host Jim Wilson as he sits down with Nabanita Nawar, co-founder of HDAX Therapeutics, to explore the groundbreaking work in targeting disease driver proteins for novel medicine development. Discover the journey from academic research to entrepreneurial success, and learn about the innovative t…
In this episode, we delve into the groundbreaking work of Dr. Jeffrey Coull and his team at Grey Matter Neurosciences. Discover how their pioneering ultrasound technology aims to enhance cognitive function in patients with Alzheimer's and other cognitive impairments. Join us as we explore the poten…
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Jim Wilson, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.
REDIG
Takk fordi du hjelper med å holde podkast-databasen oppdatert.
